• Featured Product
  • KD/KO Validated

TDP-43 (N-terminal) Rekombinanter Antikörper

TDP-43 (N-terminal) Rekombinant Antikörper für WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA

Konjugation

Unkonjugiert

Publikationen(5)

CloneNo.

16A22

Kat-Nr. : 80002-1-RR

Synonyme

TDP-43 (for IF/FC), TARDBP, TDP 43, TDP43, TDP-43



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHeLa-Zellen, C6-Zellen, K-562-Zellen, Neuro-2a-Zellen
Erfolgreiche IPHAP1 cells, HeLa-Zellen
Erfolgreiche Detektion in IHC-Autostainerhumanes Hirngewebe
Erfolgreiche Detektion in IHCMaushirngewebe, humanes Hirngewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
Erfolgreiche Detektion in IF-PRattenhirngewebe
Erfolgreiche Detektion in IF/ICCHeLa-Zellen, HepG2-Zellen, SH-SY5Y-Zellen
Erfolgreiche Detektion in FC (Intra)HeLa-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:5000-1:50000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)-AUTOSTAINERIHC-AUTOSTAINER : 1:50-1:500
Immunhistochemie (IHC)IHC : 1:1600-1:6400
Immunfluoreszenz (IF)-PIF-P : 1:800-1:3200
Immunfluoreszenz (IF)/ICCIF/ICC : 1:200-1:800
Durchflusszytometrie (FC) (INTRA)FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

80002-1-RR bindet in WB, IHC, IHC-Autostainer, IF/ICC, IF-P, FC (Intra), IP, ELISA TDP-43 (N-terminal) und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen TDP-43 (N-terminal) fusion protein Ag1231
Vollständiger Name TAR DNA binding protein
Berechnetes Molekulargewicht 43 kDa
Beobachtetes Molekulargewicht 43 kDa
GenBank-ZugangsnummerBC001487
Gene symbol TDP-43
Gene ID (NCBI) 23435
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

The TARDBP gene encodes the TDP-43 protein, initially found to repress HIV-1 transcription by binding TAR DNA. TDP-43 has since been shown to bind RNA as well as DNA, and have multiple functions in transcriptional repression, translational regulation and pre-mRNA splicing. For instance, it is reported to regulate alternate splicing of the CTFR gene. In 2006 Neumann et al. found that hyperphosphorylated, ubiquitinated and/or cleaved forms of TDP-43, collectively known as pathological TDP-43, play a major role in the disease mechanisms of ubiquitin-positive, tau- and alpha-synuclein-negative frontotemporal dementia (FTLD-U) and in amyotrophic lateral sclerosis (ALS). Proteintech's 80002-1-RR is a rabbit recombinant TDP-43 antibody recognizing N-terminal TDP-43. It recognizes the intact 43 kDa protein as well as all posttranslationally modified and truncated forms in multiple applications. Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659, 19823856, 21666678, 22193176) Recently TDP-43 has been reported to be overexpressed in triple negative breast cancer (TNBC) and it may be a potential target for TNBC diagnosis and drug design. (PMID: 29581274)

80002-1-RR antibody works well in IF experiment.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for TDP-43 (N-terminal) antibody 80002-1-RRProtokoll herunterladen
IHC protocol for TDP-43 (N-terminal) antibody 80002-1-RRProtokoll herunterladenl
IF protocol for TDP-43 (N-terminal) antibody 80002-1-RRProtokoll herunterladen
IP protocol for TDP-43 (N-terminal) antibody 80002-1-RRProtokoll herunterladen
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

bioRxiv

Patient-derived Induced Pluripotent Stem Cells as a Model to Study Frontotemporal Dementia Pathologies

Authors - Sonia Infante-Tadeo
humanIF

Nat Chem Biol

Small-molecule dissolution of stress granules by redox modulation benefits ALS models

Authors - Hiroyuki Uechi
mouseWB,IF

Neural Regen Res

5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis

Authors - Shi-Shi Jiang
humanWB,IP,IF

F1000Res

The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence

Authors - Donovan Worrall
humanIHC

J Neuropathol Exp Neurol

COVID-19 could worsen cerebral amyloid angiopathy

Authors - Julie Dewisme